ClinConnect ClinConnect Logo
Search / Trial NCT04871477

Adoption of Audio Recording in the Outpatient Supportive Care Center

Launched by M.D. ANDERSON CANCER CENTER · May 3, 2021

Trial Information

Current as of July 21, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how patients with advanced cancer feel about having their clinic visits recorded. The goal is to see if audio recordings can help patients remember important information shared during their appointments and share that information with family members or caregivers who couldn’t be there. By understanding patients’ experiences, the study aims to find out if using technology like audio recordings can improve the care they receive.

To participate in this trial, you must be at least 18 years old and have a diagnosis of advanced cancer, which includes various types of solid tumors and blood cancers. You will need to have access to a device that can record audio and be able to listen to the recording later. Participants will be contacted about a week after their visit to discuss their experiences. It’s important to note that if you have severe hearing problems or cognitive impairments, you may not be eligible for the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with the diagnosis of advanced cancer as defined as locally advanced, recurrent or metastatic cancer. Both solid and liquid tumors are eligible for the study
  • Patients who are seen in the outpatient supportive care center at M.D. Anderson Cancer Center
  • Patients who have access to a recording device or cellphone with recording technology
  • Patients who can be contacted 7 to 11 days from the clinic visit that the recording took place
  • Patients who can sign informed consent
  • Patients who are able to read and write in English
  • Patients 18 years or older
  • Exclusion Criteria:
  • Patients who have been diagnosed with delirium or cognitive impairment. This will be defined by chart review along with review of the MD Anderson Symptom Inventory (MDAS) the day of clinic visit. An MDAS of 7 or greater will be considered to define delirium in this study
  • Patients who are unwilling to sign informed consent
  • Patients who have used audio recordings before in clinic visits
  • Patients who have severe hearing impairments without access to assisted devices or programs to aid in listening to the recorded material

About M.D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center is a leading institution dedicated to cancer care, research, education, and prevention. As one of the world’s most respected cancer centers, MD Anderson focuses on innovative treatment approaches and groundbreaking clinical trials aimed at improving patient outcomes. With a multidisciplinary team of experts and state-of-the-art facilities, the center is committed to advancing cancer research and providing comprehensive, personalized care to patients. MD Anderson's clinical trials play a pivotal role in translating scientific discoveries into effective therapies, positioning the center at the forefront of cancer treatment and research.

Locations

Houston, Texas, United States

Patients applied

0 patients applied

Trial Officials

Michael J Tang

Principal Investigator

M.D. Anderson Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials